According to AC Immune's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.202. At the end of 2023 the company had a P/S ratio of 28.1.
Year | P/S ratio | Change |
---|---|---|
2023 | 28.1 | -33.44% |
2022 | 42.2 | |
2021 | N/A | -100% |
2020 | 22.9 | 317.75% |
2019 | 5.49 | -93.68% |
2018 | 86.9 | 147.55% |
2017 | 35.1 | 15.52% |
2016 | 30.4 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |